Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | KLK7 | P49862 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | UBE2N | P61088 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL805661 | 1.00 | KMT2A (0.39) | KMT2AKLK7MEN1ALDH1A1LMNA | |
| SCHEMBL803548 | 1.00 | KMT2A (0.39) | KMT2AKLK7MEN1ALDH1A1LMNA | |
| Bromide SCHEMBL187182 | 0.99 | KMT2A (0.38) | KMT2AKLK7MEN1ALDH1A1LMNA | |
| Bromide SCHEMBL186276 | 0.99 | KMT2A (0.38) | KMT2AKLK7MEN1ALDH1A1LMNA | |
| SCHEMBL803779 | 0.89 | MMP8 (0.38) | KMT2AMEN1ALDH1A1LMNARECQL | |
| SCHEMBL803862 | 0.89 | MMP8 (0.38) | KMT2AMEN1ALDH1A1LMNARECQL | |
| SCHEMBL803777 | 0.89 | MMP8 (0.38) | KMT2AMEN1ALDH1A1LMNARECQL | |
| Bromide SCHEMBL187478 | 0.88 | MMP8 (0.37) | KMT2AMEN1ALDH1A1LMNARECQL | |
| SCHEMBL15896810 | 0.88 | ALDH1A1 (0.33) | ALDH1A1LMNATDP1RECQLSMN1; SMN2 | |
| SCHEMBL15896791 | 0.88 | KLK7 (0.38) | KMT2AKLK7MEN1ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
| WO-2010097412-A1 | IONIC LIQUID SOLVENTS | DUBLIN CITY UNIVERSITY (IE) | 2010-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071661-A1 | Ionic Liquid Solvents | EBP, PAICS, HACD3 | KMT2A 3968/4885KLK7 4679/4885MEN1 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.